Clinical trial
Phase 2 Study to Determine if Allopurinol Blocks Features of Metabolic Syndrome Induced by Fructose Ingestion
NCT00639756 is registered in ClinicalTrials.gov with Hospital Mateo Orfila as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase 2 Study to Determine if Allopurinol Blocks Features of Metabolic Syndrome Induced by Fructose Ingestion
- Lead sponsor
- Hospital Mateo Orfila
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- June 30, 2008
- Completion date
- October 31, 2008
- Enrollment
- 60 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.